Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Non-Current Debt (2023 - 2025)

Q32 Bio (QTTB) has 3 years of Non-Current Debt data on record, last reported at $3.5 million in Q4 2025.

  • For Q4 2025, Non-Current Debt fell 63.66% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.5 million, down 63.66%, while the annual FY2025 figure was $3.5 million, 63.66% down from the prior year.
  • Non-Current Debt reached $3.5 million in Q4 2025 per QTTB's latest filing, down from $5.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $12.6 million in Q2 2024 and bottomed at $3.5 million in Q4 2025.
  • Average Non-Current Debt over 3 years is $7.8 million, with a median of $8.0 million recorded in 2025.
  • Peak YoY movement for Non-Current Debt: skyrocketed 108.6% in 2024, then tumbled 63.66% in 2025.
  • A 3-year view of Non-Current Debt shows it stood at $4.6 million in 2023, then surged by 108.6% to $9.6 million in 2024, then crashed by 63.66% to $3.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Debt were $3.5 million in Q4 2025, $5.0 million in Q3 2025, and $6.5 million in Q2 2025.